Molecular Devices, LLC
USPTO PatentsView assignee record - 74 granted patents across 23 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).
The verdict
According to USPTO PatentsView, Molecular ranks #4,728 of 49,997 tracked US assignees by granted-patent volume, with 74 patents across 23 technology areas.
- #4,728
- of 49,997 US assignees by volume
- Top 17%
- by Innovation Score (48.4/100)
- 18.3
- avg claims per patent
- +6%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R4728 · US Corporation #4,728 · 74 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
- GRANTS-SMALL 74 grants
- TOP-DECILE #4,728/49,997
- PHOTO-FINISH Kaohsiung Medical…
- CPC-FOCUS G01N · 23 areas
- INNOV-PAR 48.4/100
- CLAIMS-RICH 18.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-FLAT +6% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Kaohsiung Medical University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Molecular’s 48.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Molecular
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Axcelis · near
Axcelis · near
48 score
- Columbia Sportswear… · near
Columbia Sportswear… · near
48 score
- Intra-cellular… · near
Intra-cellular… · near
48 score
- Molecular Devices · this assignee
Molecular Devices · this assignee
48 score
- The Stanley Works… · near
The Stanley Works… · near
48 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Molecular's Innovation Score is 48.4/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Molecular?
Each dot is one of Molecular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Molecular’s own 18.3 claims/patent is ABOVE the 10.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Molecular's grants concentrate
Molecular Devices, LLC is a focused PatentsView assignee: 23 CPC subclasses with 54.1% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (11 grants) versus a trough of 3 in 2016. By volume, Molecular sits between Kaohsiung Medical University and Pierburg GMBH.
Molecular's three-year grant acceleration
From 2019–2021 to 2022–2024, Molecular Devices, LLC moved from 23 to 19 grants (0.83x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Molecular's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Kaohsiung Medical…
Kaohsiung Medical University
74 patents
- Keystone Retainin…
Keystone Retaining Wall Systems, LLC
74 patents
- Luigi Lavazza S p…
Luigi Lavazza S.p.A.
74 patents
- Magnolia Medical
Magnolia Medical Technologies, Inc.
74 patents
- Nanning Fulian Fu…
Nanning FuLian FuGui Precision Industrial Co., Ltd.
74 patents
- Ncstar
NcStar, Inc.
74 patents
- Physik Instrument…
Physik Instrumente (PI) GMBH & Co. KG
74 patents
- Pierburg
Pierburg GMBH
74 patents
- Molecular Devices ◀
Molecular Devices, LLC
74 patents
What this shows Molecular holds 74 patents at rank #4,728, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Molecular
By rank, the assignees closest to #4,728 in granted patent volume.
- Kaohsiung Medical University #4,724 · 74 patents
- Keystone Retaining Wall Systems, LLC #4,725 · 74 patents
- Luigi Lavazza S.p.A. #4,726 · 74 patents
- Magnolia Medical Technologies, Inc. #4,727 · 74 patents
- Nanning FuLian FuGui Precision Industrial Co., Ltd. #4,729 · 74 patents
- NcStar, Inc. #4,730 · 74 patents
- Physik Instrumente (PI) GMBH & Co. KG #4,731 · 74 patents
- Pierburg GMBH #4,732 · 74 patents
Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)
Other assignees with the most granted patents in Molecular's primary technology class.
- The Regents of the University of California 1,153 in class
- Shimadzu Corporation 1,111 in class
- Saudi Arabian OIL Company 837 in class
- Halliburton Energy Services, Inc. 816 in class
- The Boeing Company 701 in class
- General Electric Company 634 in class
- Kla-tencor Corporation 583 in class
- Massachusetts Institute of Technology 530 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Molecular, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Molecular ranks #384 of 7,863 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (48 here).
Similar claim depth
Nearest assignees by average claims per patent (18.3 here).
Molecular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 13.5% |
| 2016 | 3 | 4.1% |
| 2017 | 6 | 8.1% |
| 2018 | 11 | 14.9% |
| 2019 | 5 | 6.8% |
| 2020 | 8 | 10.8% |
| 2021 | 10 | 13.5% |
| 2022 | 5 | 6.8% |
| 2023 | 7 | 9.5% |
| 2024 | 7 | 9.5% |
| 2025partial year | 2 | 2.7% |
Which technologies does Molecular Devices, LLC patent most?
Top 15 of 23 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Molecular Devices, LLC's patent record in context - here's where to go next.
- Molecular Devices, LLC's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 54.1% of its portfolio - see every assignee active in that class. Explore G01N
- Ranked #4,728 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Molecular Devices, LLC against Kaohsiung Medical University, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 48.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.